世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

MRSA治療薬市場：MRSAタイプ別（院内感染（HA-MRSA）、市中感染（CA-MRSA））、薬剤クラス別（リポペプチド、オキサゾリジノン、セファロスポリン、テトラサイクリン、葉酸拮抗薬、その他）、適応疾患別（皮膚感染、骨・関節感染症、菌血症、動物感染症）、投与経路（経口投与、非経口投与）、流通チャネル（病院薬局、小売薬局、オンライン薬局）、地域 2024-2032


MRSA Drugs Market by MRSA Type (Hospital-Acquired (HA-MRSA), Community-Acquired (CA-MRSA)), Drug Class (Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, and Others), Disease Indication (Skin Infections, Bone and Joint Infections, Bacteremia, Animal Infections), Route of Administration (Oral Administration, Parenteral Administration), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032

世界のMRSA治療薬市場規模は2023年に38億米ドルに達した。今後、IMARC Groupは、2024年から2032年にかけて3.11%の成長率（CAGR）を示し、2032年までに50億米ドルに達すると予測している。抗生物質耐性株の増加、... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス 		2024年1月30日 US$3,899
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		149 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

世界のMRSA治療薬市場規模は2023年に38億米ドルに達した。今後、IMARC Groupは、2024年から2032年にかけて3.11%の成長率（CAGR）を示し、2032年までに50億米ドルに達すると予測している。抗生物質耐性株の増加、長期入院による医療施設での多剤耐性菌への継続的な暴露、臨床試験数の増加が市場を牽引する主な要因のいくつかである。

メチシリン耐性黄色ブドウ球菌（MRSA）は、抗生物質耐性の黄色ブドウ球菌株によって引き起こされる感染症で、一般に外科的処置を受けたり、静脈注射を受けたり、皮膚と皮膚を接触させたりした患者に発症する。MRSA治療薬は、メチシリン耐性黄色ブドウ球菌感染症に対する抗菌薬として使用され、黄色ブドウ球菌を死滅または抑制する。患者の細胞合成と免疫力を高めながら、病原体の作用を抑制します。最も一般的なMRSA治療薬は、トリメトプリム-スルファメトキサゾール、クリンダマイシン、ミノサイクリン、リネゾリド、ドキシサイクリンです。これらの薬剤は一般的に経口薬として使用され、通常7～10日間のコースで使用されます。MRSA感染症は病院や地域社会で発生する可能性があるため、MRSAの治療には、重症度に応じて経口薬や静脈内投与が行われることがあります。皮膚感染、骨感染、菌血症、さらには動物の人獣共通感染症など、さまざまなタイプの感染症の治療に使用できる多種多様な MRSA 治療薬があります。

MRSA治療薬の市場動向：
大衆の間で抗生物質耐性株が増加していることは、市場の成長を促す重要な要因である。これは、世界レベルでの院内感染（HAI）の症例数の増加に起因しています。また、長期入院による医療施設での多剤耐性菌への継続的な曝露が、二次的な院内感染の発生を招き、市場を促進している。これに加えて、MRSA感染症を発症しやすい高齢者人口の増加が、市場に弾みをつけている。さらに、さまざまな形態の細菌感染に関する意識の高まりが、MRSA治療薬の普及につながっている。これに伴い、数多くの製品革新、臨床試験の増加、新薬の導入が、市場に有利な成長機会を生み出している。しかし、新規MRSA治療薬の開発には高いコストがかかるため、市場の成長抑制要因となっている。それとは反対に、抗生物質耐性菌のスクリーニングのための臨床試験プログラムの増加とともに、様々な診断ツールにおける継続的な技術開発が、市場の前向きな見通しを生み出している。市場は、主要企業が実施する広範な研究開発（R&D）活動によってさらに後押しされている。市場に寄与するその他の要因としては、現在入手可能な製品に対するジェネリック医薬品の出現、オンラインおよびオフラインの組織化されたプラットフォームでの抗生物質の容易な入手、急速な都市化、医療費の増加などが挙げられる。

主な市場セグメンテーション
IMARC Groupは、世界のMRSA治療薬市場の各セグメントにおける主要動向の分析と、2024年から2032年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、MRSAの種類、薬剤クラス、適応疾患、投与経路、流通チャネルに基づいて市場を分類しています。

MRSAタイプ別インサイト

院内感染型（HA-MRSA）
市中感染型（CA-MRSA）

本レポートでは、MRSAタイプに基づくMRSA治療薬市場の詳細な分類と分析を提供しています。これには院内感染型（HA-MRSA）と市中感染型（CA-MRSA）が含まれる。同レポートによると、院内感染型（HA-MRSA）が最大のセグメントを占めている。

薬剤クラスの洞察

リポペプチド
オキサゾリジノン
セファロスポリン
テトラサイクリン
葉酸拮抗薬
その他

本レポートでは、薬剤クラスに基づくMRSA治療薬市場の詳細な分類と分析を行っています。これには、リポペプチド、オキサゾリジノン、セファロスポリン、テトラサイクリン、葉酸拮抗薬、その他が含まれる。報告書によると、リポペプチドが最大のセグメントを占めている。

疾患適応の洞察

皮膚感染症
骨・関節感染症
菌血症
動物感染症

本レポートでは、MRSA治療薬市場を適応疾患別に詳細に分類・分析しています。これには、皮膚感染症、骨・関節感染症、菌血症、動物感染症が含まれる。報告書によると、皮膚感染症が最大のセグメントを占めている。

投与経路の洞察

経口投与
非経口投与

本レポートでは、MRSA治療薬市場を投与経路別に詳細に分類・分析しています。これには経口投与と非経口投与が含まれる。同レポートによると、非経口投与が最大のセグメントを占めている。

流通チャネルの洞察

病院薬局
小売薬局
オンライン薬局

MRSA治療薬市場の流通チャネル別の詳細な分類と分析も報告書に記載されています。これには病院薬局、小売薬局、オンライン薬局が含まれる。同レポートによると、病院薬局が最大の市場シェアを占めている。

地域別インサイト

北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

また、北米（米国、カナダ）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、中南米（ブラジル、メキシコ、その他）、中東・アフリカなどの主要地域市場についても包括的に分析している。報告書によると、北米はMRSA治療薬の最大市場である。北米のMRSA治療薬市場を牽引する要因としては、医療費の増加、臨床試験プログラムの増加、主要企業による広範な研究開発（R&D）活動などが挙げられる。

競合情勢
本レポートでは、世界のMRSA治療薬市場における競争環境についても包括的に分析しています。主要企業の詳細プロフィールも掲載しています。対象となる企業には、AbbVie Inc.、Basilea Pharmaceutica Ltd.、Crystal Genomics Inc.、Cumberland Pharmaceuticals Inc.、Melinta Therapeutics Inc.、Paratek Pharmaceuticals, Inc.、Pfizer Inc.などがあります。

本レポートで扱う主な質問
世界のMRSA治療薬市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
MRSA治療薬の世界市場における促進要因、阻害要因、機会は何か？
主要な地域市場は？
最も魅力的なMRSA治療薬市場はどの国か？
MRSAタイプに基づく市場の内訳は？
薬剤クラスに基づく市場の内訳は？
適応症に基づく市場の内訳は？
投与経路に基づく市場の内訳は？
販売チャネル別の市場構成は？
世界のMRSA治療薬市場の競争構造は？
MRSA治療薬の世界市場における主要プレイヤー/企業は？

ページTOPに戻る


目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global MRSA Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by MRSA Type
6.1 Hospital-Acquired (HA-MRSA)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Community-Acquired (CA-MRSA)
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Lipopeptides
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oxazolidinones
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cephalosporin
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Tetracycline
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Folate Antagonist
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Disease Indication
8.1 Skin Infections
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Bone and Joint Infections
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Bacteremia
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Animal Infections
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Oral Administration
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Parenteral Administration
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Retail Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 Drivers, Restraints, and Opportunities
12.1 Overview
12.2 Drivers
12.3 Restraints
12.4 Opportunities
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 AbbVie Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Basilea Pharmaceutica Ltd
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Crystal Genomics Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Cumberland Pharmaceuticals Inc
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 Melinta Therapeutics Inc
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Paratek Pharmaceuticals, Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Pfizer Inc
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis

List of Figures
Figure 1: Global: MRSA Drugs Market: Major Drivers and Challenges
Figure 2: Global: MRSA Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: MRSA Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: MRSA Drugs Market: Breakup by MRSA Type (in %), 2023
Figure 5: Global: MRSA Drugs Market: Breakup by Drug Class (in %), 2023
Figure 6: Global: MRSA Drugs Market: Breakup by Disease Indication (in %), 2023
Figure 7: Global: MRSA Drugs Market: Breakup by Route of Administration (in %), 2023
Figure 8: Global: MRSA Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 9: Global: MRSA Drugs Market: Breakup by Region (in %), 2023
Figure 10: Global: MRSA Drugs (Hospital-Acquired (HA-MRSA)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: MRSA Drugs (Hospital-Acquired (HA-MRSA)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: MRSA Drugs (Community-Acquired (CA-MRSA)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: MRSA Drugs (Community-Acquired (CA-MRSA)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: MRSA Drugs (Lipopeptides) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: MRSA Drugs (Lipopeptides) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: MRSA Drugs (Oxazolidinones) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: MRSA Drugs (Oxazolidinones) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: MRSA Drugs (Cephalosporin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: MRSA Drugs (Cephalosporin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: MRSA Drugs (Tetracycline) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: MRSA Drugs (Tetracycline) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: MRSA Drugs (Folate Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: MRSA Drugs (Folate Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: MRSA Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: MRSA Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: MRSA Drugs (Skin Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: MRSA Drugs (Skin Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: MRSA Drugs (Bone and Joint Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: MRSA Drugs (Bone and Joint Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: MRSA Drugs (Bacteremia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: MRSA Drugs (Bacteremia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: MRSA Drugs (Animal Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: MRSA Drugs (Animal Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: MRSA Drugs (Oral Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: MRSA Drugs (Oral Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: MRSA Drugs (Parenteral Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: MRSA Drugs (Parenteral Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: MRSA Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: MRSA Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: MRSA Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: MRSA Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: MRSA Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: MRSA Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: North America: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: North America: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: United States: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: United States: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Canada: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Canada: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Asia-Pacific: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Asia-Pacific: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: China: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: China: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Japan: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Japan: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: India: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: India: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: South Korea: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: South Korea: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Australia: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Australia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Indonesia: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Indonesia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Europe: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Europe: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Germany: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Germany: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: France: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: France: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: United Kingdom: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: United Kingdom: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Italy: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Italy: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Spain: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Spain: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Russia: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Russia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Latin America: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Latin America: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Brazil: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Brazil: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Mexico: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Mexico: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Others: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Middle East and Africa: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Middle East and Africa: MRSA Drugs Market: Breakup by Country (in %), 2023
Figure 92: Middle East and Africa: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Global: MRSA Drugs Industry: Drivers, Restraints, and Opportunities
Figure 94: Global: MRSA Drugs Industry: Value Chain Analysis
Figure 95: Global: MRSA Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: MRSA Drugs Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: MRSA Drugs Market Forecast: Breakup by MRSA Type (in Million US$), 2024-2032
Table 3: Global: MRSA Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 4: Global: MRSA Drugs Market Forecast: Breakup by Disease Indication (in Million US$), 2024-2032
Table 5: Global: MRSA Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 6: Global: MRSA Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 7: Global: MRSA Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: MRSA Drugs Market: Competitive Structure
Table 9: Global: MRSA Drugs Market: Key Players

　

ページTOPに戻る


　

Summary

The global MRSA drugs market size reached US$ 3.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2032, exhibiting a growth rate (CAGR) of 3.11% during 2024-2032. The rising prevalence of antibiotic resistant strains development, continual exposure to multidrug-resistant organisms in healthcare facilities due to prolonged hospital admission and the growing number of clinical trials represent some of the key factors driving the market.

Methicillin-resistant staphylococcus aureus (MRSA) is an infection caused by antibiotic-resistant strains of staphylococcus aureus that generally occurs in patients who undergo surgical procedures, receive intravenous tubing, or come in contact with each other skin-to-skin. The MRSA drugs are used as antimicrobial agents against methicillin-resistant staphylococcus aureus infection in order to kill or restrain it. They inhibit the actions of pathogens while enhancing the patient's cellular synthesis and immunity. The most common MRSA drugs consist of trimethoprim-sulfamethoxazole, clindamycin, minocycline, linezolid, or doxycycline. These drugs are generally used as oral medication, usually on a course of seven to ten days. MRSA infections can arise from hospitals or from community, hence the treatment for MRSA can sometimes involve the administration of oral medications and intravenous (IV) medications, depending on the severity. There are a wide variety of MRSA drugs available that can be used for the treatment of different types of infections, including skin infections, bone infections, bacteremia, and even zoonotic infections in animals.

MRSA Drugs Market Trends:
The rising prevalence of antibiotic resistant strains development among the masses is a significant factor driving the growth of the market. This can be attributed to the increase in the number of cases of hospital-acquired infections (HAIs) on the global level. Also, the continual exposure to multidrug-resistant organisms in healthcare facilities due to prolonged hospital admission is resulting in the development of secondary nosocomial infections, thereby propelling the market. In addition to this, the growing geriatric population that is more susceptible to developing MRSA infections is providing an impetus to the market. Moreover, the augmenting awareness regarding different forms of bacterial infection is leading to a higher uptake of MRSA drugs. In line with this, numerous product innovations, growing number of clinical trials and the introduction of novel drug variants are creating lucrative growth opportunities in the market. However, the high costs involved in developing novel MRSA drug variants is acting as major growth restraining-factor for the market. On the contrary, continual technological developments in various diagnostic tools, along with the increasing number of clinical trial programs for the screening of antibiotic resistant strains of bacteria, are creating a positive market outlook. The market is further impelled by extensive research and development (R&D) activities conducted by the key players. Some of the other factors contributing to the market include the emergence of generic drugs against presently available products, easy availability of antibiotics across online and offline organized platforms, rapid urbanization, and increasing medical expenditure.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global MRSA drugs market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on MRSA type, drug class, disease indication, route of administration, and distribution channel.

MRSA Type Insights

Hospital-Acquired (HA-MRSA)
Community-Acquired (CA-MRSA)

The report has provided a detailed breakup and analysis of the MRSA drugs market based on the MRSA type. This includes Hospital-Acquired (HA-MRSA) and Community-Acquired (CA-MRSA). According to the report, Hospital-Acquired (HA-MRSA) represented the largest segment.

Drug Class Insights

Lipopeptides
Oxazolidinones
Cephalosporin
Tetracycline
Folate Antagonist
Others

The report has provided a detailed breakup and analysis of the MRSA drugs market based on the drug class. This includes lipopeptides, oxazolidinones, cephalosporin, tetracycline, folate antagonist, and others. According to the report, lipopeptides represented the largest segment.

Disease Indication Insights

Skin Infections
Bone and Joint Infections
Bacteremia
Animal Infections

The report has provided a detailed breakup and analysis of the MRSA drugs market based on the disease indication. This includes skin infections, bone and joint infections, bacteremia, and animal infections. According to the report, skin Infections represented the largest segment.

Route of Administration Insights

Oral Administration
Parenteral Administration

The report has provided a detailed breakup and analysis of the MRSA drugs market based on the route of administration. This includes oral administration and parenteral administration. According to the report, parenteral administration represented the largest segment.

Distribution Channel Insights

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

A detailed breakup and analysis of the MRSA drugs market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for MRSA drugs. Some of the factors driving the North America MRSA drugs market include the rising medical expenditure, the increasing number of clinical trial programs, extensive research and development (R&D) activities conducted by key players, etc.

Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global MRSA drugs market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AbbVie Inc., Basilea Pharmaceutica Ltd, Crystal Genomics Inc., Cumberland Pharmaceuticals Inc., Melinta Therapeutics Inc, Paratek Pharmaceuticals, Inc., Pfizer Inc, etc.

Key Questions Answered in This Report:
How has the global MRSA drugs market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global MRSA drugs market?
What are the key regional markets?
Which countries represent the most attractive MRSA drugs markets?
What is the breakup of the market based on the MRSA type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the disease indication?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What is the competitive structure of the global MRSA drugs market?
Who are the key players/companies in the global MRSA drugs market?



ページTOPに戻る


Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global MRSA Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by MRSA Type
6.1 Hospital-Acquired (HA-MRSA)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Community-Acquired (CA-MRSA)
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Lipopeptides
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oxazolidinones
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cephalosporin
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Tetracycline
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Folate Antagonist
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Disease Indication
8.1 Skin Infections
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Bone and Joint Infections
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Bacteremia
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Animal Infections
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Oral Administration
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Parenteral Administration
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Retail Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 Drivers, Restraints, and Opportunities
12.1 Overview
12.2 Drivers
12.3 Restraints
12.4 Opportunities
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 AbbVie Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Basilea Pharmaceutica Ltd
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Crystal Genomics Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Cumberland Pharmaceuticals Inc
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 Melinta Therapeutics Inc
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Paratek Pharmaceuticals, Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Pfizer Inc
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis

List of Figures
Figure 1: Global: MRSA Drugs Market: Major Drivers and Challenges
Figure 2: Global: MRSA Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: MRSA Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: MRSA Drugs Market: Breakup by MRSA Type (in %), 2023
Figure 5: Global: MRSA Drugs Market: Breakup by Drug Class (in %), 2023
Figure 6: Global: MRSA Drugs Market: Breakup by Disease Indication (in %), 2023
Figure 7: Global: MRSA Drugs Market: Breakup by Route of Administration (in %), 2023
Figure 8: Global: MRSA Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 9: Global: MRSA Drugs Market: Breakup by Region (in %), 2023
Figure 10: Global: MRSA Drugs (Hospital-Acquired (HA-MRSA)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: MRSA Drugs (Hospital-Acquired (HA-MRSA)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: MRSA Drugs (Community-Acquired (CA-MRSA)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: MRSA Drugs (Community-Acquired (CA-MRSA)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: MRSA Drugs (Lipopeptides) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: MRSA Drugs (Lipopeptides) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: MRSA Drugs (Oxazolidinones) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: MRSA Drugs (Oxazolidinones) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: MRSA Drugs (Cephalosporin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: MRSA Drugs (Cephalosporin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: MRSA Drugs (Tetracycline) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: MRSA Drugs (Tetracycline) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: MRSA Drugs (Folate Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: MRSA Drugs (Folate Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: MRSA Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: MRSA Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: MRSA Drugs (Skin Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: MRSA Drugs (Skin Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: MRSA Drugs (Bone and Joint Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: MRSA Drugs (Bone and Joint Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: MRSA Drugs (Bacteremia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: MRSA Drugs (Bacteremia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: MRSA Drugs (Animal Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: MRSA Drugs (Animal Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: MRSA Drugs (Oral Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: MRSA Drugs (Oral Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: MRSA Drugs (Parenteral Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: MRSA Drugs (Parenteral Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: MRSA Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: MRSA Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: MRSA Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: MRSA Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: MRSA Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: MRSA Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: North America: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: North America: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: United States: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: United States: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Canada: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Canada: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Asia-Pacific: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Asia-Pacific: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: China: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: China: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Japan: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Japan: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: India: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: India: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: South Korea: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: South Korea: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Australia: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Australia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Indonesia: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Indonesia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Europe: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Europe: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Germany: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Germany: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: France: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: France: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: United Kingdom: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: United Kingdom: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Italy: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Italy: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Spain: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Spain: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Russia: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Russia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Latin America: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Latin America: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Brazil: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Brazil: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Mexico: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Mexico: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Others: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Middle East and Africa: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Middle East and Africa: MRSA Drugs Market: Breakup by Country (in %), 2023
Figure 92: Middle East and Africa: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Global: MRSA Drugs Industry: Drivers, Restraints, and Opportunities
Figure 94: Global: MRSA Drugs Industry: Value Chain Analysis
Figure 95: Global: MRSA Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: MRSA Drugs Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: MRSA Drugs Market Forecast: Breakup by MRSA Type (in Million US$), 2024-2032
Table 3: Global: MRSA Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 4: Global: MRSA Drugs Market Forecast: Breakup by Disease Indication (in Million US$), 2024-2032
Table 5: Global: MRSA Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 6: Global: MRSA Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 7: Global: MRSA Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: MRSA Drugs Market: Competitive Structure
Table 9: Global: MRSA Drugs Market: Key Players

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

IMARC Services Private Limited. 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/09/20　10:26

143.76 円

160.81 円

193.57 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.